Page last updated: 2024-11-07

prednisone and Empty Sella Syndrome

prednisone has been researched along with Empty Sella Syndrome in 2 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Empty Sella Syndrome: A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: (1) primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; (2) secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yang, LY1
Lin, S1
Xie, QB1
Yin, G1
Chaabane, H1
Meziou, TJ1
Amouri, M1
Ayadi, L1
Boudawara, T1
Elloumi, M1
Turki, H1

Reviews

1 review available for prednisone and Empty Sella Syndrome

ArticleYear
Central diabetes insipidus unveiled by glucocorticoid therapy in a patient with an empty sella: A case report and literature review.
    Medicine, 2020, Oct-23, Volume: 99, Issue:43

    Topics: Adolescent; Adrenal Insufficiency; Adult; Aged; Aged, 80 and over; Deamino Arginine Vasopressin; Dia

2020

Other Studies

1 other study available for prednisone and Empty Sella Syndrome

ArticleYear
[Adult multi-organ Langerhans cell histiocytosis with fatal outcome].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:5

    Topics: Adult; Empty Sella Syndrome; Fatal Outcome; Female; Histiocytosis, Langerhans-Cell; Humans; Hyperpro

2013